Perlmutter Cancer Centre — New York, New York

Perlmutter Cancer Centre is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Centre has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Hormone-sensitive Prostate Cancer, Early Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Centre?

Perlmutter Cancer Centre has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Centre conducted?

Perlmutter Cancer Centre has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Hormone-sensitive Prostate Cancer, Early Breast Cancer.

Is Perlmutter Cancer Centre accredited by Crixeo Health?

Perlmutter Cancer Centre has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Centre?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.